High prevalence of the CD14-159CC genotype in patients infected with severe acute respiratory syndrome-associated coronavirus

Clinical and Vaccine Immunology

Volumn 14, Issue 12, 2007, Pages 1644-1645

  Yuan, Fang F ^a,c,d   Boehm, Ingrid ^a   Chan, Paul K S ^b   Marks, Katherine ^a   Tang, Julian W ^b   Hui, David S C ^b   Sung, Joseph J Y ^b   Dyer, Wayne B ^a,c   Geczy, Andrew F ^c   Sullivan, John S ^a,c  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c University of Sydney   (Australia)

^d ARCBS Endeavour   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ARTICLE; CD14 GENE; CONTROLLED STUDY; CORONAVIRUS; DNA POLYMORPHISM; GENE; GENOTYPE; HEREDITY; HONG KONG; HUMAN; INNATE IMMUNITY; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; SEVERE ACUTE RESPIRATORY SYNDROME; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS INFECTION;

ANTIGENS, CD14; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HONG KONG; HUMANS; IMMUNITY, NATURAL; ODDS RATIO; POLYMORPHISM, GENETIC; PREVALENCE; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SEVERITY OF ILLNESS INDEX; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 38049004890     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00100-07     Document Type: Article

References (10)

1. Arbour, N. C., E. Lorenz, B. C. Schutte, J. Zabner, J. N. Kline, M. Jones, K. Frees, J. L. Watt, and D. A. Schwartz. 2000. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25:187-191.
2. Baldini, M., I. C. Lohman, M. Halonen, R. P. Erickson, P. G. Holt, and F. D. Martinez. 1999. A polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am. J. Respir. Cell Mol. Biol. 20:976-983.
3. Ben-Ali, M., M. R. Barbouche, S. Bousnina, A. Chabbou, and K. Dellagi. 2004. Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin. Diagn. Lab. Immunol. 11:625-626.
4. Compton, T., E. A. Kurt-Jones, K. W. Boehme, J. Belko, E. Latz, D. T. Golenbock, and R. W. Finberg. 2003. Human cytomegalovirus actives inflammatory cytokine responses via CD14 and Toll-like receptor 2. J. Virol. 77:4588-4596.
5. Kabesch, M., K. Hasemann, V. Schickinger, I. Tzotcheva, A. Bohnert, D. Carr, M. Baldini, H. Hackstein, W. Leupold, S. K. Weiland, F. D. Martinez, E. Mutius, and G. Bein. 2004. A promoter polymorphism in the CD14 gene is associated with elevated levels of soluble CD14 but not with IgE or atopic diseases. Allergy 59:520-525.
6. Kang, T. J., and G. T. Chae. 2001. Detection of toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol. Med. Microbiol. 31:53-58.
7. Leung, T. F., N. L. S. Tang, G. W. K. Wong, and T. F. Fok. 2005. CD14 and Toll-like receptors: potential contribution of genetic factors and mechanisms to inflammation and allergy. Curr. Drug. Targets Inflamm. Allergy 4:169-175.
8. Lorenz, E., K. L. Frees, and D. A. Schwartz. 2001. Determination of the TLR4 genotype using allele-specific PCR. BioTechniques 31:22-24.
9. Schröder, N. W. J., C. Hermann, L. Hamann, U. B. Göbel, T. Hartung, and R. R. Schumann. 2003. High frequency of polymorphism Arg753Gln of the Toll-like receptor-2 gene detected by a novel allele-specific PCR. J. Mol. Med. 81:368-372.
10. Yuan, F. F., J. Tanner, P. K. S. Chan, S. Biffin, W. B. Dyer, A. F. Geczy, J. W. Tang, D. S. C. Hui, J. J. Y. Sung, and J. S. Sullivan. 2005. Influence of FcγIIRA and MBL polymorphisms on severe acute respiratory syndrome. Tissue Antigens 66:291-296.